A study, supported by the National Institute for Health Research (NIHR) Clinical Research Network (CRN), has found that bowel cancer patients are more likely to survive in research-active hospitals.
Even patients who are not involved in the trials themselves benefit from being in hospitals where a large amount of clinical research is taking place.
Using data from the NIHR CRN, researchers Dr Amy Downing and Professor Eva Morris at the University of Leeds discovered that people are more likely to survive after operations in these types of hospitals and are more likely to still be alive five years afterwards. There was nearly a four per cent increase in the five-year survival rate for those treated in highly research-active hospitals.
Read more here.